AzTrials
AzTrials

DepressionNCT04223115

A Randomized Controlled Study of Digitalized Cognitive Behavioral Intervention for Antenatal Depression

A study testing Digitalized CBT with phone coaching and Psychoeducation about depression in people with Depression and Antenatal Depression, run by University of Turku at 1 site in Finland.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The main objective of the current research project is to evaluate the effectiveness of the digitalized cognitive behavioral therapy program including telephone coaching for antenatal depressive symptoms. Read more about this study

Who is it for?
Ages 18 to 55 years, women only
Conditions the study is for
Depression, Antenatal Depression
What is being tested?
Digitalized CBT with phone coaching and Psychoeducation about depression
Could I receive a placebo?
No, everyone receives an active treatment
How many people
634 participants
Where
1 siteFinland
Study dates
10 Jun 2021to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • fluent in written and spoken Finnish or Swedish
  • access to computer or mobile phone with internet
  • between 12 and 22 weeks pregnant
  • screening and baseline score on the EPDS ≥10 points

Who cannot join

  • lifetime history of psychotic disorder (e.g. schizophrenia, schizoaffective disorder, bipolar disorder, psychotic depression)
  • active suicidal ideation
  • severe substance abuse or dependence
  • actively ongoing psychotherapy
  • participates in another intervention study aiming at treating the symptoms of antenatal depression
  • multiple pregnancy

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • University of Turku

    Turku

Other trials in Finland

About this study

Official title: Randomized Controlled Trial of Digitalized Cognitive Behavioral Therapy With Telephone Coaching for Mothers Suffering From Depression During Pregnancy

The main objective of the current research project is to evaluate the effectiveness of the digitalized cognitive behavioral therapy program including telephone coaching for antenatal depressive symptoms. The participants are screened from the general population of pregnant women, as a part of the routine maternity health care check-ups. Mothers with depressive symptoms will be randomized into intervention group receiving guided digitalized treatment program or control group receiving education material about depression in digital form.

Being tested
Digitalized CBT with phone coaching, Psychoeducation about depression
Keywords
digital intervention, cognitive behavioral therapy, antenatal depression
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digitalized CBT with phone coachingBehavioural

    Digitally delivered CBT intervention with weekly phone coaching

  • Psychoeducation about depressionOther

    Psychoeducational material about depression in a digitalized form

Study groups in NCT04223115
Study groupRoleWhat they receive
Digitalized CBT intervention with phone coachingExperimentalParticipants receive weekly sessions of internet-based CBT, including telephone coaching
Receives: Behavioral: Digitalized CBT with phone coaching
Psychoeducation about depressionActive comparatorParticipants receive psychoeducative material about depression in digitalized form.
Receives: Other: Psychoeducation about depression

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the Edinburgh Postnatal Depression Scale (EPDS)

    EPDS is a ten-item self-report questionnaire originally developed to screen for postpartum depression. The respondents are asked about the symptoms of depression. The total score ranges from 0 to 30.

    Measured: Baseline and 11 weeks after randomization

Secondary outcomes (5)
  1. Change in the General Anxiety Disorder 7-item scale (GAD-7)

    To assess the change in anxiety symptoms from baseline to follow-up, we will use the Generalized Anxiety Disorder 7-item Scale (GAD-7) (Spitzer, Kroenke, Williams, \& Löwe, 2006), which is a brief screening measure including seven items asking about anxiety symptoms experienced in the previous two weeks.

    Measured: Baseline and 11 weeks after randomization

  2. Change in the Beck Depression Inventory II (BDI-II)

    To assess the change in depressive symptoms BDI-II will be used.

    Measured: Baseline and 11 weeks after randomization

  3. Social Phobia Inventory (SPIN)

    To assess the change in Social Phobia SPIN will be used

    Measured: Baseline and 11 weeks after randomization

  4. Pregnancy-Related Anxiety Questionnaire-Revised (PRAQ)

    To assess the change in pregnancy related anxiety PRAQ will be used

    Measured: Baseline and 11 weeks after randomization

  5. Perceived Stress Scale (PSS)

    To assess the change in perceived stress PSS will be used

    Measured: Baseline and 11 weeks after randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2020
  2. Study start10 Jun 2021
  3. Primary completion31 Jul 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
634 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04223115
Sponsor's protocol ID
DEPMOM-2020
Status last verified
May 2026
First submitted
7 Jan 2020
Last updated
15 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sourander A, Korpilahti-Leino T, Ristkari T, Koffert T, Arrhenius B, Stahlberg T, Hinkka-Yli-Salomaki S, Berglund M, Upadhyaya S, Wan Mohd Yunus WMA, Sinokki A, Hagg R, Marjamaki A, Kankaanranta I, Palmroth J, Sourander S, Zadkova A, Casagrande L, Yamada Y, Karjalainen S, Matinolli HM, Vuori M. Internet-assisted cognitive behavioral therapy with telephone coaching versus an educational control for antenatal depression: protocol for a randomized controlled trial with population-based screening. Front Psychiatry. 2025 Nov 3;16:1604352. doi: 10.3389/fpsyt.2025.1604352. eCollection 2025.

    PubMed 41256941

Questions about this trial

What is this clinical trial studying?

A study testing Digitalized CBT with phone coaching and Psychoeducation about depression in people with Depression and Antenatal Depression, run by University of Turku at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the Edinburgh Postnatal Depression Scale (EPDS) (time frame: Baseline and 11 weeks after randomization). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04223115, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in